Rigel Pharmaceuticals, Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 71332 (Rigel Pharmaceuticals, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
8
Package NDCs
6
Products
6
Active listings
0
Discontinued
4
Ingredients
0
Therapeutic classes
3
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 6 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Gavreto Pralsetinib 100 mg/1 CAPSULE | 71332-0006-12 | — | On market | View → |
| REZLIDHIA olutasidenib 150 mg/1 CAPSULE | 71332-0005-01 | — | On market | View → |
| TAVALISSE FOSTAMATINIB 100 mg/1 TABLET | 71332-0001-01 | — | On market | View → |
| TAVALISSE FOSTAMATINIB 150 mg/1 TABLET | 71332-0002-01 | — | On market | View → |
| VEPPANU vepdegestrant 200 mg/1 TABLET, FILM COATED | 71332-0008-30 | — | On market | View → |
| VEPPANU vepdegestrant 100 mg/1 TABLET, FILM COATED | 71332-0007-30 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.